Samuel Backenroth - Mar 31, 2023 Form 4 Insider Report for Vascular Biogenics Ltd. (VBLT)

Role: Chief Financial Officer
Signature: /s/ Samuel Backenroth
Stock symbol: VBLT
Transactions as of: Mar 31, 2023
Transactions value $: $0
Form type: 4
Date filed: 4/18/2023, 04:36 PM
Previous filing: Jan 3, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VBLT	Ordinary Shares	Options Exercise		+525K			525K	Mar 31, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VBLT	Restricted Stock Units	Options Exercise	$0	-525K	-75%	$0.00	175K	Mar 31, 2023	Ordinary Shares	525K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the vesting and settlement of a portion of restricted stock units ("RSUs") previously granted to the Reporting Person. Each RSU represents a contingent right to receive one Ordinary Share, par value NIS 0.01, with an exercise price of NIS 0.01 per Ordinary Share.
F2	75% of the RSUs vested on March 31, 2023, with the remaining 25% vesting on August 9, 2024. The RSUs have no expiration date and have an exercise price of NIS 0.01 per Ordinary Share.